Dr. Isabel Cunningham: Improving AML Results. Hint: It's Not (Yet) a Drug
Dr. Isabel Cunningham: Improving AML Results. Hint: It's Not (Yet) a Drug
Interview by L Scott Zoeller
20110012
2011 Jan 12
Top Stories of 2010
Dr. Isabel Cunningham: Improving AML Results. Hint: It's Not (Yet) a Drug
Top Stories of 2010. 2011 Jan 12, Interview by L Scott Zoeller
Abstract
Dr. Isabel Cunningham is Adjunct Associate Research Scientist, Division of Hematology Oncology, Columbia University College of Physicians and Surgeons. OncologySTAT: In your view, which development in leukemia that occurred in 2010 could have the most significant impact on oncology?Dr. Cunningham: Acute leukemia, treated the world over for 40 years with combinations of the same drugs, has seen just a few agents for particular subtypes (ATRA, imatinib, arsenic trioxide) introduced over this time....
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
